First human trial shows an AI-created super-antigen vaccine is safe, targets SARS-CoV-2, SARS, and bat coronaviruses, potentially ending constant vaccine updates.
First AI-Designed Universal Coronavirus Vaccine Passes Human Trial
First human trial shows an AI-created super-antigen vaccine is safe, targets SARS-CoV-2, SARS, and bat coronaviruses, potentially ending constant vaccine updates.